FARGALS IN THE TREATMENT OF NECROTIC INFECTIONS OF SOFT  TISSUES ON THE BACKGROUND OF DIABETES MELLITUS

У.К. КАСИМОВ1, А.О. ОХУНОВ2, А.Т.МОМИНОВ3, Н.М. МАЛИКОВ4, Ф. М. АБДУРАХМАНОВ5, ОТАЖОНОВ Ж.Х.

dc.contributor.author	У.К. КАСИМОВ1, А.О. ОХУНОВ2, А.Т.МОМИНОВ3, Н.М. МАЛИКОВ4, Ф. М. АБДУРАХМАНОВ5, ОТАЖОНОВ Ж.Х.
dc.date.accessioned	2023-02-10T04:19:49Z
dc.date.available	2023-02-10T04:19:49Z
dc.date.issued	2023-02
dc.identifier.issn	2776-0960
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/6279
dc.description.abstract	One of the most difficult areas of purulent surgery is the development of a surgical infection of soft tissues against the background of diabetes mellitus, when necrotic changes dominate. To accelerate the process of cleansing and subsequent healing of soft tissue wounds in patients with diabetes mellitus, antibacterial drugs, proteolytic enzymes, as well as ointment dressings are used, depending on the stage of the wound process using methods physical impact. In this regard, the purpose of this study is: to study the antibacterial and anti inflammatory effect of the drug FarGALS in necrotic infections of soft tissues against the background of diabetes mellitus. Studies were conducted in 103 patients with purulent-inflammatory diseases who were on inpatient treatment at the Republican Center for Purulent Surgery and Surgical Complications of Diabetes Mellitus	en_US
dc.language.iso	en	en_US
dc.subject	purulent wound; necrotizing infection, anti-inflammatory activity; wound area; FarGALS, diabetes mellitus.	en_US
dc.title	FARGALS IN THE TREATMENT OF NECROTIC INFECTIONS OF SOFT TISSUES ON THE BACKGROUND OF DIABETES MELLITUS	en_US
dc.type	Article	en_US